Skip to content
drillr.ai
Sign up

ALZN

Alzamend Neuro, Inc.

NASDAQ · Healthcare · Biotechnology · US

$1.66
−2.35%
Ask drillr

Income statement

MetricTTM2026202520242023
Revenue
Total Revenue—————
Cost of Revenue27.7K————
Gross Profit(27.7K)————
Operating Expenses
R&D Expense3.6M3.6M1.4M6.5M7.4M
SG&A Expense5.1M5.1M3.1M3.5M7.4M
General & Admin Expense5.1M5.1M2.7M3.2M6.7M
Selling & Marketing Expense——347.3K247.3K742.6K
Other Expenses(27.7K)————
Total Operating Expenses8.7M8.8M4.5M9.9M14.9M
Cost and Expenses8.8M8.8M4.5M9.9M14.9M
Operating Income (EBIT)(8.8M)(8.8M)(4.5M)(9.9M)(14.9M)
Non-Operating
Interest Income1.1K1.1K———
Interest Expense(6.6K)(6.6K)18.0K10.1K7.7K
Net Interest Income7.7K7.7K(18.0K)(10.1K)(7.7K)
Other Non-Op Income/Expense(5.5K)(5.5K)(18.0K)(10.1K)(7.7K)
Non-Operating Income (excl Interest)—(1.1K)———
EBT (Pre-Tax Income)(8.8M)(8.8M)(4.5M)(9.9M)(14.9M)
Income Tax Expense—————
Bottom Line
Net Income(8.8M)(8.8M)(4.5M)(9.9M)(14.9M)
Earnings from Cont. Ops(8.8M)(8.8M)(4.5M)(9.9M)(14.9M)
Earnings from Discont. Ops—————
Bottom Line Net Income(8.8M)(8.8M)(5.1M)(9.9M)(14.9M)
Per Share
Basic EPS($2.90)($2.63)($11.32)($132.33)($205.97)
Diluted EPS($2.90)($2.63)($11.32)($132.33)($205.97)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding3.3M3.3M3980007500072000
Diluted Shares Outstanding3.3M3.3M4507997517472236
Profitability Metrics
EBITDA(8.8M)(8.7M)(4.4M)(9.9M)(14.8M)
D&A—110.7K50.7K50.7K23.1K
EBIT(8.8M)(8.8M)(4.5M)(9.9M)(14.9M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Apr 1, 2026